The Global Medicines Supply Chain

Building a resilient medicines supply chain 

The medicines supply chain is a complex global marketplace of manufacturers, suppliers, and distributors. Disruptions to this system can prevent medicines from reaching the people who need them.​ 

USP works with regulators, industry leaders, and other scientific experts to develop quality standards and solutions to enable a more resilient medicines supply chain. 

Building a resilient supply chain requires:

predicting drug shortages

Predicting and preventing drug shortages

Currently, no single entity has a comprehensive view of the medicines supply chain. End-to-end data and insights can help decision-makers identify potential vulnerabilities, understand root causes, and take action to improve the resilience and reliability of the supply chain.  

The Annual Drug Shortages Report explains trends and drivers
The Annual Drug Shortages Report explains trends and drivers

The USP Medicine Supply Map identifies four main drivers that make a drug vulnerable to shortage: low prices, geographic concentration, manufacturing complexity, and quality concerns. Understanding these drivers can help leaders take more effective action to help people access to the medicines they need.

Read the report

The Vulnerable Medicines List offers a data-driven approach to resilience
The Vulnerable Medicines List offers a data-driven approach to resilience

A data-driven, vulnerability-informed approach can help inform stakeholder actions – including drug makers, purchasing entities such as hospitals and GPOs, and policymakers – to effectively build a more resilient medicines supply chain. 

Access the list

The USP Medicine Supply Map gives actionable insights
The USP Medicine Supply Map gives actionable insights

The vast majority of active pharmaceutical ingredients made for the U.S. market are made outside of the U.S. Decision-makers need end-to-end supply chain data to incentivize resilience. 

Read the insights

USP standards

Utilizing standards to foster quality

Supply chain disruptions can create, or stem from, quality issues, that put patients at risk of receiving substandard or falsified medicines. Standards and standards-based solutions can accelerate innovation, support manufacturing scalability, strengthen regulatory frameworks, and foster trust in the quality of medicines.  

From the sourcing of raw materials to packaging, labeling, distribution, and point-of-care administration, standards help ensure quality across the pharmaceutical product lifecycle. 

standards and medicine quality
Standards bolster supply chain resilience

Standards and other solutions help stakeholders ensure quality throughout the product lifecycle and the supply chain.

Learn more

PPQT protects the medicine supply and patients from unvalidated testing methods
PPQT protects the medicine supply and patients from unvalidated testing methods

The USP PPQT program equips manufacturers with validated testing methods, combatting misinformation about drug quality, encouraging adherence to life-saving therapies for patients, and preserving the reputation of generic medicines. 

Learn about PPQT

Girl with IV Bag
Compounding standards support healthcare practitioners during public health emergencies

USP, with input from its Compounding Expert Committee, provided standards and monographs to help frontline workers address shortages of manufactured IV fluids related to Hurricane Helene. 

Access the resource

pharmaceutical manufacturing

Scaling efficient, innovative, and diversified manufacturing

A strong, geographically distributed manufacturing base enables a more secure medicines supply chain. USP supports efforts to boost domestic production, increase competition, and mitigate risk of disruptions and shortages.

These efforts include promoting geographic diversification of manufacturing for key drugs and their active ingredients and components, bolstering U.S. manufacturing capacity, and reducing the technical barriers to aid in wider adoption of advanced manufacturing technologies (AMT). 

medicine ingredients
Tackling medicine supply shortages starting with their ingredients

Secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients.

Learn more

geographic diversity in supply chain
Building geographic diversity in the medicines supply chain

Expanding manufacturing helps to limit losses, spread risk, and secure multiple sources for manufacturing and production.

Read the paper

continuous manufacturing knowledge center
Continuous Manufacturing Knowledge Center (CMKC)

The CMKC is a free digital knowledge management resource for capturing, organizing, and updating rapidly expanding knowledge about continuous manufacturing, as well as an online community network where experts can collaborate to close existing knowledge gaps.

Join the community